Patient Provider Communication Larch Supplement

项目总结 本申请是为了回应被确认为非CA-CA的特殊利益通知(NOSI)而提交的 23-041.肺癌筛查有可能对公众健康产生深远的好处；然而，坚持 在美国，肺癌筛查仍然很低。多层次数字健康干预，其目标是 患者、临床医生和医疗保健系统提供了一个有希望的解决方案来解决肺癌的缺口 放映。数字健康可以通过增加患者覆盖面来改善干预中以患者为中心的态度， 通过教育实现可获得性和理解。我们建议利用 落叶松试验(R01CA262015)通过建议的补充研究回应NOT-CA-23-041。这个 建议的补充研究在父母资助的范围内，这是一项务实的随机试验，测试患者- 以促进坚持重复肺癌筛查为中心的干预措施。正在测试的一种干预措施是 病人之声视频，病人教育视频，通过Kaiser Permanente提供 华盛顿患者门户在肺癌筛查阴性扫描后。补充研究的目标是 定义并了解哪些人群会对肺癌的数字健康通信做出反应 使用患者语音视频进行筛选，将其作为一个“用例”。更重要的是，我们的发现还将确定哪些 患者群体无法通过数字健康消息传递获得，这可能会影响未来的重点领域 增加用于癌症筛查的数字健康消息的公平性。对于这项补充研究，我们的目标是：1) 评估与Kaiser Permanente Washington患者门户相关的患者、提供者和系统因素 访问和参与门户中的视频消息传递；以及2)了解患者与 患者的声音、视频和对多媒体筛查干预措施的态度，以及与关键线人的访谈。 拟议的混合方法补充研究将提高我们对患者参与的理解 数字健康干预，具有很高的潜力为未来的研究提供信息，以改善肺癌筛查和治疗 增加癌症护理服务提供的公平性。

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 23-041. Screening for lung cancer has the potential for a profound public health benefit; however, adherence to lung cancer screening remains low in the United States. Multilevel digital health interventions, which target patients, clinicians, and healthcare systems, offer a promising solution to address the gaps in lung cancer screening. Digital health can improve patient-centeredness in interventions by increasing patient reach, accessibility, and understanding through education. We propose to leverage the unique infrastructure of the Larch trial (R01CA262015) via the proposed supplemental study in response to NOT-CA-23-041. The proposed supplemental study is within the scope of parent grant, a pragmatic randomized trial testing patient- centered interventions to promote adherence to repeat lung cancer screening. One intervention being tested is the Patient Voices Video, an educational video for patients, which is delivered via Kaiser Permanente Washington patient portal after a negative lung cancer screening scan. The supplemental study goal is to define and understand which populations would be responsive to digital health communication for lung cancer screening using the Patient Voice Video as a ‘use case’. More importantly, our findings will also identify which patient populations are not reached via digital health messaging, which can influence future focal areas to increase equity in digital health messaging for cancer screening. For this supplemental study, our aims are: 1) Evaluate patient-, provider- and system-factors associated with Kaiser Permanente Washington patient portal access and engagement with video messaging in the portal; and 2) Understand patient engagement with Patient Voices Video and attitudes toward multimedia screening interventions with key informant interviews. The proposed mixed-methods supplement study will improve our understanding of patient engagement with digital health interventions, with high potential to inform future research to improve lung cancer screening and increase equity in cancer care delivery.